Skip to content
Drug recall · FDA · Published December 20, 2016

Sun Pharmaceutical Industries, Inc. recalls buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88)

Failed Dissolution Specifications; 18 month stability time point

🇺🇸 FDA recall #D-0445-2017DrugSUN PHARMACEUTICAL INDUSTRIES INC ›
Take action

Contact the company & request your remedy

Recalling firmSun Pharmaceutical Industries, Inc.270 Prospect Plains Rd, N/A · Cranbury, NJ 08512-3605
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
Write-up in progress

We’re still writing up this recall

We break every recall down into plain English — this one’s still on our list. Until our write-up is ready, the official FDA hazard and remedy below have the full, accurate details.

Source Page by GovInfoNow · govinfonow.com/recall/42114-sun-pharmaceutical-industries-inc-recalls-bupropion-hydrochloride-extended-release-tablets · Recall date December 20, 2016 · FDA enforcement record: FDA #D-0445-2017

Cite this page

“Sun Pharmaceutical Industries, Inc. recalls buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88).” GovInfoNow, recall dated December 20, 2016. https://govinfonow.com/recall/42114-sun-pharmaceutical-industries-inc-recalls-bupropion-hydrochloride-extended-release-tablets. Based on FDA recall #D-0445-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0445-2017%22&limit=1).

How to tell if you have this one

  • Brand
    SUN PHARMACEUTICAL INDUSTRIES INC
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class III
  • Status
    Terminated
  • Distribution
    Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-0445-2017buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88) and c) 500 (NDC 47335-737-13) count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India; a) 60 count JKP1184A , exp 2/17; JKP1576A, JKP2517A, JKP2527A, exp 04/17; JKP2768A exp 06/17; KP3895A, JKP4051A, exp 08/17; JKP4052A, JKP4605A exp 09/17 b) 100 count JKP0702A exp 01/17; JKP1186A exp 02/17; JKP2766A, exp 05/17; JKP3368A, JKP3369A exp 06/17; JKP3419A, JKP3420A exp 07/17; JKP4056A, JKP4603A, exp 09/17 c) 500 count JKP0093A, JKP0094A, JKP0703A, JKP0704A, exp 01/17; JKP1182A, JKP1183A, JKP1185A, exp 02/17; JKP1187A, JKP1188A, JKP1577A, JKP1578A, JKP2528A, exp 04/17; JKP2764A, JKP2765A, JKP2767A, exp 05/17; JKP3370A, JKP3371A, exp 06/17; JKP3372A, JKP3417A, JKP3418A, JKP3421A, JKP3889A, exp 07/17; JKP3892A, JKP3893A, JKP3894A, exp 08/17; JKP4053A, JKP4054A, JKP4055A, JKP4057A, JKP4600A, JKP4601A, JKP4602A, exp 09/17; JKP4742A, JKP4743A, exp 10/17a) 141,068 bottles b) 56,834 bottles c) 61,692 bottles47335-736-86, 47335-736-88, 47335-736-08, 47335-736-13, 47335-737-86, 47335-737-88, 47335-737-08, 47335-737-13, 47335-738-86, 47335-738-88, 47335-738-08, 47335-738-13
D-0446-2017buPROPion Hydrochloride Extended-release Tablets, USP (SR), 200 mg, 60 count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India NDC 47335-0738-86; JKP0905A 04/1711,618 bottles—
Take action

Contact SUN PHARMACEUTICAL INDUSTRIES INC

We’ve drafted a message you can send SUN PHARMACEUTICAL INDUSTRIES INC to request your refund or repair — edit it as you like.

Subject: Recall D-0445-2017 — SUN PHARMACEUTICAL INDUSTRIES INC Sun Pharmaceutical Industries, Inc. recalls buPROPion Hydrochlori

Hello,

I own a Sun Pharmaceutical Industries, Inc. recalls buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, a) 60 (NDC 47335-737-86), b) 100 (NDC 47335-737-88) that is covered by recall D-0445-2017 from SUN PHARMACEUTICAL INDUSTRIES INC.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0445-2017 (December 20, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0445-2017 to see it in context.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA